הבדלים בין גרסאות בדף "אולנזפין טבע 5 מ"ג - Olanzapine teva 5 mg"
שורה 8: | שורה 8: | ||
|התוויה= | |התוויה= | ||
Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. | Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. | ||
− | |שם יצרן = | + | |שם יצרן = יצרנים |
*[[TEVA OPERATIONS POLAND SP.ZO.O]] | *[[TEVA OPERATIONS POLAND SP.ZO.O]] | ||
*[[TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY]] | *[[TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY]] |
גרסה מ־19:41, 7 בינואר 2014
נתוני הסל
נתוני הסל |
---|
הגבלות הסל
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת |
התוויה בסל
Acute and maintenance treatment of schizophrenia. Zyprexa is indicated for the management of the manifestations of psychotic disorders. Zyprexa is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment, Zyprexa is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. |
שימוש בסל |
תאריך הכללה בסל
16/12/1997 |
מסגרת הכללה בסל
הרחבת סל בריאות 2014 טיפול בסכיזופרניה - הרחבת מסגרת ההכללה בסל - מתן גם כקו טיפול ראשון |